Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Indian Drug Makers, Activists Say MNCs Hide Facts In Patents

This article was originally published in PharmAsia News

Executive Summary

Major Indian drug makers are joining with public-health activists to accuse multinational drug companies of being less than forthcoming in their patent applications. The Indian groups say the MNCs are attempting to hide the identity of the molecules they use in their formulas. A patent expert said some companies attempt to call their creations "a novel compound" or "new pharmaceutical substance" to avoid identification of the chemicals or molecules involved. He said there are rules against accepting such applications, but said the rules are broken more often than they are followed. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068487

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel